Post-menopausal medication may help prevent new cases of breast cancer
Jul 26, 2011
In breast cancer breakthroughs news, an existing drug may hold the answer in the ongoing search for preventative measures.
A recent study has found that Aromasin could have preventative capabilities in addition to being prescribed to treat post-menopausal women with early stage, hormone-receptor-positive breast cancer, the Amber Gazette reports. The drug reduces the risk of cancer recurring in women with this condition, and also helps shrink tumors and prevent spreading in women with advanced breast cancer or metastatic hormone-receptor positive breast cancer.
Pfizer, who makes Aromasin, helped fund a clinical trial of more than 4,500 women. "We thought it would work [as a preventative], but until it was proved in the clinical trial we didn't know for sure," Dr. Beth DuPree, medical director of the Holy Redeemer Breast Health Program, told the source. "Those with a 30 to 40 percent chance of getting breast cancer can decrease their risk by 65 percent" by taking Aromasin, DuPree asserts.
Anything that could help prevent breast cancer would be a welcome addition to the global medical market. More than 230,000 new cases of breast cancer are expected to be reported in 2011 in the United States alone, according to the American Cancer Society.